Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: TropMed Pharma Consulting
Street 1: 10 Brampton Chase
Street 2:
City: Lower Shiplake
Province: Oxfordshire
Post Code: RG9 3BX
Country: United Kingdom of Great Britain and Northern Ireland
Phone: + 44 (118) 940 3349
Email: info@tropmedpharma.com
Web Site: http://www.tropmedpharma.com

Focal Point Contact Information

Salutation: Mr
First Name: Ian
Last Name: Boulton
Title: Managing Director
Email: ian.boulton@tropmedpharma.com
Phone: +44 (118) 940 3349

Alternate Focal Point Contact Information

Salutation: NA
First Name: NA
Last Name: NA
Title:  
Email: NA
Phone:  

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Small consultancy specialising in working with companies and organisations active in communicable diseases that disproportionately affect the developing world, especially in the field of strategy and the transition from late stage product development to full commercialisation. We are involved with the Global Fund Market Dynamics Advisory Group and its work of TB drugs and diagnostic market dynamics.
 
Total number of staff in your organization: 1 - 5
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? Unable to disclose amount
How did you hear about the Stop TB Partnership: Other partners
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
N/A
 

Geographical Reach

Which country is your headquarters located in: United Kingdom of Great Britain and Northern Ireland
Which WHO region is the main focus of your work: African
Which countries do you do operate in:
(This includes countries you are conducting activities in)
United Kingdom of Great Britain and Northern Ireland

Specializations

Research and Development
Technical Assistance

Specializations in Countries

Research and Development United Kingdom of Great Britain and Northern Ireland
Technical Assistance United Kingdom of Great Britain and Northern Ireland

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment.

Drug-Resistant TB:
Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment.

TB-HIV:
Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment.

New Diagnostics:
Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment.

New TB Drugs:
Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment.

Declaration

Declaration of interests:
GlaxoSmithKline (shareholder & pensioner)
Consultancy contracts in the past with UNITAID & Global Fund.

Application date: November 26, 2012
Last updated: May 11, 2017